SVCM

Saturn V Capital Management Portfolio holdings

AUM $456M
1-Year Est. Return 177.94%
This Quarter Est. Return
1 Year Est. Return
+177.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$247M
AUM Growth
+$48.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
26
New
Increased
Reduced
Closed

Top Buys

1 +$22M
2 +$13.9M
3 +$10.1M
4
LENZ
LENZ Therapeutics
LENZ
+$10M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$7.31M

Top Sells

1 +$27.8M
2 +$6.46M
3 +$5.2M
4
SNDX icon
Syndax Pharmaceuticals
SNDX
+$5.06M
5
SLN
Silence Therapeutics
SLN
+$4.05M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INZY
26
DELISTED
Inozyme Pharma
INZY
-499,254